Published in Int J Exp Pathol on November 02, 2010
Early-stage thymic carcinoma: is adjuvant therapy required? J Thorac Dis (2013) 0.83
Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas. Int J Clin Exp Pathol (2015) 0.75
Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors. Clin Exp Med (2015) 0.75
Androgen receptor in prostate cancer. Endocr Rev (2004) 7.92
Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer (1991) 2.32
Eosinophils as a marker for invasion in cervical squamous neoplastic lesions. Int J Gynecol Pathol (2002) 1.63
What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol (2006) 1.53
Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol (1977) 1.36
Primary thymic carcinomas. Am J Surg Pathol (1982) 1.35
Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol (1982) 1.31
KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol (2004) 1.28
Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest (2005) 1.06
Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms. BMC Clin Pathol (2005) 1.04
Pulmonary and pleural thymoma. Diagnostic application of lymphocyte markers to the thymoma of unusual site. Am J Clin Pathol (1988) 1.00
Thymic carcinomas: histopathological varieties and immunohistochemical study. Am J Surg Pathol (1990) 0.97
Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol (2009) 0.96
Multiple thymic squamous cell carcinomas associated with mixed type thymoma. Am J Surg Pathol (1987) 0.95
Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer (2006) 0.93
An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component. Am J Surg Pathol (1986) 0.93
Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology (2002) 0.93
CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol (1998) 0.92
Carcinomas of the cervix with intense stromal eosinophilia. Cancer (1981) 0.89
In vitro evidence for participation of DEC-205 expressed by thymic cortical epithelial cells in clearance of apoptotic thymocytes. Int Immunol (2003) 0.89
Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol (2003) 0.88
Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Appl Immunohistochem Mol Morphol (2000) 0.87
Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression. Cancer (2005) 0.86
Carcinoma of the cervix with massive eosinophilia. Br J Obstet Gynaecol (1988) 0.85
Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms. Am J Surg Pathol (2007) 0.85
Intense eosinophilic stromal infiltration in carcinoma of the uterine cervix: a clinicopathologic study of 14 cases. Gynecol Oncol (1983) 0.85
Eosinophils as a marker for invasion in vulvar squamous neoplastic lesions. Int J Gynecol Pathol (2002) 0.84
Analysis of cell cycle regulator proteins in encapsulated thymomas. Clin Cancer Res (2005) 0.83
The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. Am J Surg Pathol (1995) 0.79
Expression of cyclins D1, D3 and p27 in thymic epithelial tumors. Interact Cardiovasc Thorac Surg (2004) 0.79
CD117 in soft tissue sarcomas. Am J Clin Pathol (2002) 0.77
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol (2010) 2.39
Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res (2009) 1.96
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res (2004) 1.80
Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol (2006) 1.80
Content validation of a novel robotic surgical simulator. BJU Int (2010) 1.72
Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw (2014) 1.71
Robot-assisted intracorporeal ileal conduit: Marionette technique and initial experience at Roswell Park Cancer Institute. Urology (2010) 1.70
Face validation of a novel robotic surgical simulator. Urology (2010) 1.69
The Preschool Confusion Assessment Method for the ICU: Valid and Reliable Delirium Monitoring for Critically Ill Infants and Children. Crit Care Med (2016) 1.69
Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology (2011) 1.67
Extramammary Paget's disease presenting as alopecia neoplastica. J Cutan Pathol (2008) 1.53
Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem (2004) 1.53
Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer (2005) 1.52
Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer. Urology (2013) 1.52
Cognitive skills assessment during robot-assisted surgery: separating the wheat from the chaff. BJU Int (2015) 1.50
Delay to formalin fixation effect on breast biomarkers. Mod Pathol (2009) 1.46
Outcome of renal insufficiency patients undergoing coronary artery bypass graft surgery. Cardiology (2008) 1.46
Does body mass index impact the performance of robot-assisted intracorporeal ileal conduit? J Endourol (2012) 1.45
Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Ann Surg Oncol (2006) 1.39
Short-term patient-reported quality of life after robot-assisted radical cystectomy using the Convalescence and Recovery Evaluation. Urology (2012) 1.38
Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol (2005) 1.35
Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons. Can J Urol (2009) 1.28
Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol (2013) 1.25
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. J Clin Oncol (2004) 1.23
Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer (2006) 1.20
Aberrant crypt foci. Anticancer Res (2006) 1.19
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol Endocrinol (2012) 1.16
Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncol Rep (2008) 1.16
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol (2004) 1.13
Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg (2010) 1.12
Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw (2012) 1.11
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer (2005) 1.10
Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res (2003) 1.10
Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer (2005) 1.10
Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature. Int J Clin Exp Pathol (2008) 1.09
Malignant glomus tumor: a case report and review of literature, focusing on its clinicopathologic features and immunohistochemical profile. Am J Dermatopathol (2005) 1.08
Angiolymphoid hyperplasia with eosinophilia: a classic clinical presentation with histologic features of angiosarcoma. Dermatol Surg (2002) 1.08
Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol (2009) 1.08
Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Mod Pathol (2011) 1.07
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 1.06
Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Clin Colorectal Cancer (2006) 1.05
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clin Cancer Res (2005) 1.05
Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms. BMC Clin Pathol (2005) 1.04
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Lasers Surg Med (2011) 1.04
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer (2006) 1.03
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax (2006) 1.02
Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clin Chem (2006) 1.01
Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol (2006) 1.01
Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol (2011) 1.01
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol (2011) 1.01
Malignant pleural mesothelioma. J Natl Compr Canc Netw (2012) 1.01
Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors. Int J Radiat Oncol Biol Phys (2008) 1.01
IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. Am J Clin Pathol (2010) 1.01
Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses. Head Neck (2004) 1.00
Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res (2009) 0.99
Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma. Ann Clin Lab Sci (2008) 0.99
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun (2004) 0.98
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma. Int J Gynecol Cancer (2011) 0.97
Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg (2003) 0.97
Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. Hepatogastroenterology (2004) 0.96
Peripheral primitive neuroectodermal tumor of the mandible with cytogenetic and molecular biology aberrations. J Oral Maxillofac Surg (2005) 0.96
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. Int J Oncol (2005) 0.95
ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PLoS One (2013) 0.95
Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol (2002) 0.94
Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. J Gastrointest Oncol (2012) 0.94
Pulmonary malignant granular cell tumor. World J Surg Oncol (2003) 0.94
Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J (2004) 0.93
Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines. BMC Cancer (2005) 0.93
Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res (2004) 0.92
Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res (2009) 0.92
Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res (2013) 0.92
Melanotic schwannoma with drop metastases to the caudal spine and high expression of CD117 (c-kit). J Neurooncol (2005) 0.92
Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis. BJU Int (2008) 0.92
Expression of thyroid transcription factor-1 in colorectal carcinoma. Appl Immunohistochem Mol Morphol (2010) 0.91
Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer. Clin Lung Cancer (2009) 0.91
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. Am J Clin Pathol (2010) 0.91
Post-laparoscopic cholecystectomy pain: effects of intraperitoneal local anesthetics on pain control--a randomized prospective double-blinded placebo-controlled trial. Am Surg (2008) 0.90
Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol (2012) 0.90
Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates. Ann Clin Lab Sci (2007) 0.90
Merkel cell carcinoma. J Natl Compr Canc Netw (2009) 0.90
Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia. Cancer J (2005) 0.90
Leukemoid reaction in pancreatic cancer: a case report and review of the literature. JOP (2006) 0.90
Development and validation of a composite scoring system for robot-assisted surgical training--the Robotic Skills Assessment Score. J Surg Res (2013) 0.90
Characteristics of the lax vowel space in dysarthria. J Speech Lang Hear Res (2005) 0.89